Clinical practice of precision medicine in lymphoma

Abstract

Background: Lymphoma is the most common malignancy in blood system. There are still unmet treatment needs in Hodgkin's and non-Hodgkin's lymphoma. Materials & Methods: We searched reviews and clinical trials on genetic medicine of lymphoma in Pubmed, the prevelance of lymphoma in Pubmed as well as SEER. Results: Genetic analysis helps the practice in lymphoma. For some molecules have become diagnostic markers in some subtypes of lymphoma. Some genetic disorder could forecast the prognosis. Besides, new target drug could be chosen as individual treatment according to the genetic changes in lymphoma cells. Conclusion: Precision medicine has shown promising future in the field of lymphoma.